Yes she is, and she has a pretty successful track record. I feel investors quit reading after they seen the cream trials would last two years. They clearly say they will export the tablet upon completion of a safety/efficacy trial against another drug. This could be huge IMO. They probably couldn’t export to the U.S. or Canada, but Europe and Asia would be in their sights.

Also, maybe I’m asking a stupid question here. But just because they’re converting shares, does it absolutely mean they’ve sold them? If he’s like me after doing a PP, I just want them shares registered and into my account, even though I’m not selling.